NasdaqCM - Nasdaq Real Time Price USD
Telomir Pharmaceuticals, Inc. (TELO)
2.5000
+0.1400
+(5.93%)
At close: May 16 at 4:00:00 PM EDT
2.5000
0.00
(0.00%)
After hours: May 16 at 4:05:09 PM EDT
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 1 | 1 | 1 | 1 |
Avg. Estimate | -0.08 | -0.08 | -0.31 | -0.28 |
Low Estimate | -0.08 | -0.08 | -0.31 | -0.28 |
High Estimate | -0.08 | -0.08 | -0.31 | -0.28 |
Year Ago EPS | -- | -- | -0.56 | -0.31 |
Revenue Estimate
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 1 | 1 | 1 | 1 |
Avg. Estimate | -- | -- | -- | 1.5M |
Low Estimate | -- | -- | -- | 1.5M |
High Estimate | -- | -- | -- | 1.5M |
Year Ago Sales | -- | -- | -- | -- |
Sales Growth (year/est) | -- | -- | 0.00% | 0.00% |
Earnings History
Currency in USD | 12/31/2024 | 3/31/2025 |
---|---|---|
EPS Est. | -0.05 | -0.1 |
EPS Actual | -0.1 | -0.07 |
Difference | -0.05 | 0.03 |
Surprise % | -100.00% | 30.00% |
EPS Trend
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | -0.08 | -0.08 | -0.31 | -0.28 |
7 Days Ago | -0.1 | -0.1 | -0.4 | -0.36 |
30 Days Ago | -0.1 | -0.1 | -0.4 | -0.36 |
60 Days Ago | -0.1 | -0.1 | -0.4 | -0.36 |
90 Days Ago | -0.05 | -0.04 | -0.23 | -0.18 |
EPS Revisions
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | 1 | 1 | 1 | 1 |
Down Last 30 Days | 1 | 1 | 1 | 1 |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
TELO | -- | -- | 44.64% | 9.68% |
S&P 500 | 13.31% | 2.69% | 7.81% | 13.74% |
Related Tickers
IKT Inhibikase Therapeutics, Inc.
2.0100
-0.99%
CMND Clearmind Medicine Inc.
0.9900
+2.06%
TCON TRACON Pharmaceuticals, Inc.
0.0322
0.00%
ARMP Armata Pharmaceuticals, Inc.
1.3500
-3.57%
RENB Renovaro Inc.
0.3220
-3.22%
MEIP MEI Pharma, Inc.
2.0800
-1.42%
IMU.AX Imugene Limited
0.0220
-4.35%
VIRX Viracta Therapeutics, Inc.
0.0170
0.00%
CHRO Channel Therapeutics Corporation
1.0000
+4.17%
ACRV Acrivon Therapeutics, Inc.
1.1500
+4.55%